发布求助
文献互助 智能选刊 最新文献

PharmacoEconomics Spanish Research Articles最新文献

筛选
英文 中文
Consideraciones económicas para la evaluación de los medicamentos huérfanos en las decisiones de financiación en España 西班牙资助决策中孤儿药物评估的经济考虑
PharmacoEconomics Spanish Research Articles Pub Date : 2013-04-16 DOI: 10.1007/S40277-013-0014-7
J. Darbá, Lisette Kaskens
{"title":"Consideraciones económicas para la evaluación de los medicamentos huérfanos en las decisiones de financiación en España","authors":"J. Darbá, Lisette Kaskens","doi":"10.1007/S40277-013-0014-7","DOIUrl":"https://doi.org/10.1007/S40277-013-0014-7","url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2013-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122270734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Evidencia del coste-efectividad de la implantación transcatéter de la prótesis valvular aórtica (TAVI) Edwards SAPIEN en pacientes de alto riesgo con estenosis aórtica sintomática en España: resultados preliminares 经导管植入Edwards SAPIEN主动脉瓣假体(TAVI)在西班牙高危症状主动脉狭窄患者中的成本效益证据:初步结果
PharmacoEconomics Spanish Research Articles Pub Date : 2013-03-26 DOI: 10.1007/S40277-013-0001-Z
Ignacio Ferreira-González, V. Serra, Omar Abdul, S. Paz, L. Lizán, Kurt Banz, A. Ribera, Carlos Sureda, A. Igual, Bruno García del Blanco, Juan Ángel, D. García-Dorado, P. Tornos
{"title":"Evidencia del coste-efectividad de la implantación transcatéter de la prótesis valvular aórtica (TAVI) Edwards SAPIEN en pacientes de alto riesgo con estenosis aórtica sintomática en España: resultados preliminares","authors":"Ignacio Ferreira-González, V. Serra, Omar Abdul, S. Paz, L. Lizán, Kurt Banz, A. Ribera, Carlos Sureda, A. Igual, Bruno García del Blanco, Juan Ángel, D. García-Dorado, P. Tornos","doi":"10.1007/S40277-013-0001-Z","DOIUrl":"https://doi.org/10.1007/S40277-013-0001-Z","url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2013-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129828837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Análisis coste-efectividad de la terapia adyuvante con trastuzumab para el tratamiento de cáncer de mama en estadios iniciales 曲妥珠单抗辅助治疗早期乳腺癌的成本效益分析
PharmacoEconomics Spanish Research Articles Pub Date : 2013-03-08 DOI: 10.1007/S40277-013-0003-X
L. Lindner, A. Vieta, C. Rodríguez, A. Barnadas, P. Sánchez-Rovira, I. Martín
{"title":"Análisis coste-efectividad de la terapia adyuvante con trastuzumab para el tratamiento de cáncer de mama en estadios iniciales","authors":"L. Lindner, A. Vieta, C. Rodríguez, A. Barnadas, P. Sánchez-Rovira, I. Martín","doi":"10.1007/S40277-013-0003-X","DOIUrl":"https://doi.org/10.1007/S40277-013-0003-X","url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"65 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2013-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131991374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Análisis coste-utilidad de valganciclovir durante 200 días frente a 100 días post-trasplante como tratamiento preventivo de la enfermedad por citomegalovirus en receptores de trasplante renal de alto riesgo 缬更昔洛韦移植后200天与100天作为高危肾移植受者巨细胞病毒疾病预防治疗的成本效益分析
PharmacoEconomics Spanish Research Articles Pub Date : 2013-03-08 DOI: 10.1007/S40277-013-0002-Y
L. Guirado-Perich, C. Fernández-Rivera, J. Torre-Cisneros, Eliazar Sabater-Cabrera, E. Ruíz-Beato, Cristina Varela
{"title":"Análisis coste-utilidad de valganciclovir durante 200 días frente a 100 días post-trasplante como tratamiento preventivo de la enfermedad por citomegalovirus en receptores de trasplante renal de alto riesgo","authors":"L. Guirado-Perich, C. Fernández-Rivera, J. Torre-Cisneros, Eliazar Sabater-Cabrera, E. Ruíz-Beato, Cristina Varela","doi":"10.1007/S40277-013-0002-Y","DOIUrl":"https://doi.org/10.1007/S40277-013-0002-Y","url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2013-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117158648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Demostración de equivalencia terapéutica previa al análisis de minimización de costes 在成本最小化分析之前证明治疗等效性
PharmacoEconomics Spanish Research Articles Pub Date : 2012-11-01 DOI: 10.1007/BF03320880
J. G. García, M. Díaz
{"title":"Demostración de equivalencia terapéutica previa al análisis de minimización de costes","authors":"J. G. García, M. Díaz","doi":"10.1007/BF03320880","DOIUrl":"https://doi.org/10.1007/BF03320880","url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"47 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116462227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Análisis económico de acontecimientos adversos producidos por sunitinib, bevacizumab + interferón alfa e interferón alfa en pacientes con carcinoma de células renales metastásico en México 墨西哥转移性肾细胞癌患者舒尼替尼、贝伐单抗+干扰素和干扰素不良事件的经济分析
PharmacoEconomics Spanish Research Articles Pub Date : 2012-11-01 DOI: 10.1007/BF03320883
M. Ramírez, Gustavo Peniche, J. Rodríguez, Carlos Nuño-Langre, E. Muciño-Ortega, J. Mould-Quevedo
{"title":"Análisis económico de acontecimientos adversos producidos por sunitinib, bevacizumab + interferón alfa e interferón alfa en pacientes con carcinoma de células renales metastásico en México","authors":"M. Ramírez, Gustavo Peniche, J. Rodríguez, Carlos Nuño-Langre, E. Muciño-Ortega, J. Mould-Quevedo","doi":"10.1007/BF03320883","DOIUrl":"https://doi.org/10.1007/BF03320883","url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130196562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
El uso de evaluación económica para la toma de decisiones en intervenciones oncológicas: la experiencia de México, Colombia y Brasil 在肿瘤干预中使用经济评估决策:来自墨西哥、哥伦比亚和巴西的经验
PharmacoEconomics Spanish Research Articles Pub Date : 2012-11-01 DOI: 10.1007/BF03320881
I. Contreras-Hernández, F. Prisco, N. Alvis-Guzman, S. D. Stefani
{"title":"El uso de evaluación económica para la toma de decisiones en intervenciones oncológicas: la experiencia de México, Colombia y Brasil","authors":"I. Contreras-Hernández, F. Prisco, N. Alvis-Guzman, S. D. Stefani","doi":"10.1007/BF03320881","DOIUrl":"https://doi.org/10.1007/BF03320881","url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129909008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Eficiencia de la combinación dutasterida y tamsulosina para el tratamiento de la hiperplasia benigna de próstata en España dutasteride和tamsulosin联合治疗西班牙良性前列腺增生的疗效
PharmacoEconomics Spanish Research Articles Pub Date : 2012-11-01 DOI: 10.1007/BF03320882
F. Antoñanzas, F. Brenes, J. M. Cózar, A. Fernández-Pro, J. Molero, A. Huerta, I. Pérez-Escolano
{"title":"Eficiencia de la combinación dutasterida y tamsulosina para el tratamiento de la hiperplasia benigna de próstata en España","authors":"F. Antoñanzas, F. Brenes, J. M. Cózar, A. Fernández-Pro, J. Molero, A. Huerta, I. Pérez-Escolano","doi":"10.1007/BF03320882","DOIUrl":"https://doi.org/10.1007/BF03320882","url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132832012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impacto presupuestario de trabectedina y doxorubicina liposomal pegilada (DLP) para el tratamiento del cáncer de ovario parcialmente sensible al platino 特拉贝替丁和聚脂质体阿霉素(DLP)治疗部分铂敏感卵巢癌的预算影响
PharmacoEconomics Spanish Research Articles Pub Date : 2012-09-01 DOI: 10.1007/BF03320878
I. Oyagüez, G. Cajaraville, J. M. D. Campo, M. Carreras, J. Montalar, J. M. Rubio, Beatriz García Andrés, M. Casado
{"title":"Impacto presupuestario de trabectedina y doxorubicina liposomal pegilada (DLP) para el tratamiento del cáncer de ovario parcialmente sensible al platino","authors":"I. Oyagüez, G. Cajaraville, J. M. D. Campo, M. Carreras, J. Montalar, J. M. Rubio, Beatriz García Andrés, M. Casado","doi":"10.1007/BF03320878","DOIUrl":"https://doi.org/10.1007/BF03320878","url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128341884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Coste-efectividad de roflumilast en el tratamiento de pacientes con enfermedad pulmonar obstructiva crónica en España 罗氟米司特在西班牙治疗慢性阻塞性肺病患者的成本效益
PharmacoEconomics Spanish Research Articles Pub Date : 2012-09-01 DOI: 10.1007/BF03320879
L. Lindner, J. Ancochea, J. Aparicio, L. Camíns
{"title":"Coste-efectividad de roflumilast en el tratamiento de pacientes con enfermedad pulmonar obstructiva crónica en España","authors":"L. Lindner, J. Ancochea, J. Aparicio, L. Camíns","doi":"10.1007/BF03320879","DOIUrl":"https://doi.org/10.1007/BF03320879","url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121117941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信